Bisphosphonates in the adjuvant treatment of early breast cancer

por Gnant, M
Publicado 2009

The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis

por Hadji, P., Coleman, R., Gnant, M., Green, J.
Publicado 2012

Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma

por Schmidinger, M, Wenzel, C, Locker, G J, Muehlbacher, F, Steininger, R, Gnant, M, Crevenna, R, Budinsky, A C
Publicado 2001

Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy

por Schindl, M., Függer, R., Götzinger, P., Längle, F., Zitt, M., Stättner, S., Kornprat, P., Sahora, K., Hlauschek, D., Gnant, M
Publicado 2018

Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer.

por Fiegl, M., Tueni, C., Schenk, T., Jakesz, R., Gnant, M., Reiner, A., Rudas, M., Pirc-Danoewinata, H., Marosi, C., Huber, H.
Publicado 1995

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

por Coates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J.
Publicado 2015

Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry

por Singer, C.F., Jahn, S.W., Rudas, M., Bago-Horvath, Z., Fitzal, F., Abete, L., Moinfar, F., Gnant, M., Filipits, M.
Publicado 2022

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer...

por Fitzal, F, Filipits, M, Rudas, M, Greil, R, Dietze, O, Samonigg, H, Lax, S, Herz, W, Dubsky, P, Bartsch, R, Kronenwett, R, Gnant, M
Publicado 2015

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

por Burstein, H.J., Curigliano, G., Thürlimann, B., Weber, W.P., Poortmans, P., Regan, M.M., Senn, H.J., Winer, E.P., Gnant, M.
Publicado 2021

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series

por Zagouri, F, Sergentanis, T N, Koutoulidis, V, Sparber, C, Steger, G G, Dubsky, P, Zografos, G C, Psaltopoulou, T, Gnant, M, Dimopoulos, M-A, Bartsch, R
Publicado 2013

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2– disease: results from 1204 patients in the randomized ABCSG-8 trial

por Fitzal, F, Filipits, M, Fesl, C, Rudas, M, Greil, R, Balic, M, Moinfar, F, Herz, W, Dubsky, P, Bartsch, R, Ferree, S, Schaper, C, Gnant, M
Publicado 2021

Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer

por Pfeiler, G, Königsberg, R, Hadji, P, Fitzal, F, Maroske, M, Dressel-Ban, G, Zellinger, J, Exner, R, Seifert, M, Singer, C, Gnant, M, Dubsky, P
Publicado 2013

Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analy...

por Minichsdorfer, C., Fuereder, T., Leutner, M., Singer, C.F., Kacerovsky-Strobl, S., Egle, D., Greil, R., Balic, M., Fitzal, F., Pfeiler, G., Frantal, S., Bartsch, R., Gnant, M.
Publicado 2022

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER(+), HER2(−) early breast cancer

por Exner, R, Bago-Horvath, Z, Bartsch, R, Mittlboeck, M, Retèl, V P, Fitzal, F, Rudas, M, Singer, C, Pfeiler, G, Gnant, M, Jakesz, R, Dubsky, P
Publicado 2014

A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

por Schippinger, W, Jagoditsch, M, Sorré, C, Gnant, M, Steger, G, Hausmaninger, H, Mlineritsch, B, Schaberl-Moser, R, Mischinger, H J, Hofbauer, F, Holzberger, P, Mittlböck, M, Jakesz, R
Publicado 2005

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the...

por Gnant, M, Pfeiler, G, Stöger, H, Mlineritsch, B, Fitzal, F, Balic, M, Kwasny, W, Seifert, M, Stierer, M, Dubsky, P, Greil, R, Steger, G, Samonigg, H, Fesl, C, Jakesz, R
Publicado 2013

Prognostic impact of breast cancer subtypes in elderly patients

por Bergen, E. S., Tichy, C., Berghoff, A. S., Rudas, M., Dubsky, P., Bago-Horvath, Z., Mader, R. M., Exner, R., Gnant, M., Zielinski, C. C., Steger, G. G., Preusser, M., Bartsch, R.
Publicado 2016

Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value

por Michlmayr, A, Bachleitner-Hofmann, T, Baumann, S, Marchetti-Deschmann, M, Rech-Weichselbraun, I, Burghuber, C, Pluschnig, U, Bartsch, R, Graf, A, Greil, R, Allmaier, G, Steger, G, Gnant, M, Bergmann, M, Oehler, R
Publicado 2010

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer

por Schippinger, W, Samonigg, H, Schaberl-Moser, R, Greil, R, Thödtmann, R, Tschmelitsch, J, Jagoditsch, M, Steger, G G, Jakesz, R, Herbst, F, Hofbauer, F, Rabl, H, Wohlmuth, P, Gnant, M, Thaler, J
Publicado 2007

Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases

por Bartsch, R, Berghoff, A, Pluschnig, U, Bago-Horvath, Z, Dubsky, P, Rottenfusser, A, DeVries, C, Rudas, M, Fitzal, F, Dieckmann, K, Mader, R M, Gnant, M, Zielinski, C C, Steger, G G
Publicado 2012